An artificial feeding system for maintenance and growth of hematophagous insects is disclosed to comprise a blood-free diet formulation and a feeding device. The blood-free diet formulation comprises effective amounts of a protein source and a carbohydrate source, wherein the blood-free diet formulation is suitable for egg production and colony maintenance of hematophagous insects. The feeding device comprises a diet reservoir for receiving the blood-free diet formulation and a feeding platform for hematophagous insects to feed the blood-free diet formation from the diet reservoir.

A composition for a food supplement comprising a substance capable of exerting an anti-oedemigenous and/or anti-inflammatory action in soft organic tissues, a substance capable of exerting an antioxidant action and at least one substance facilitating penetration, through a cell membrane, of the substance capable of exerting an anti-oedemigenous and/or anti-inflammatory action and/or of the substance capable of exerting an antioxidant action, for use in the treatment of female infertility.

An artificial feeding system for maintenance and growth of hematophagous insects is disclosed to comprise a blood-free diet formulation and a feeding device. The blood-free diet formulation comprises effective amounts of a protein source and a carbohydrate source, wherein the blood-free diet formulation is suitable for egg production and colony maintenance of hematophagous insects. The feeding device comprises a diet reservoir for receiving the blood-free diet formulation and a feeding platform for hematophagous insects to feed the blood-free diet formation from the diet reservoir.

A formulation comprising platelet rich plasma (PRP) for treatment of patients who have experienced brain injury, consisting of: a mixture of human plasma composed of pluripotent adult stem cells comprising very small embryonic like stem cells from autologous plasma or allogeneic plasma, D5W, glutathione, methylcobalamin, and regular insulin. The formulation is infused directly adjacent to a patient's brain through the nostrils or nares of the nasal cavity. Treatment using the formulation may be supplemented with one or more therapies including hyperbaric oxygen therapy (HBOT), cranial osteopathic therapy, intravenous (IV) nutrition, electroencephalographic (EEG) biofeedback, low level laser therapy (LLLT), transcranial magnetic stimulation (TMS), additional PRP pluripotent adult stem cell treatments, and a ketogenic diet and medium-chain triglyceride (MCT) oil therapy.

A formulation comprising platelet rich plasma (PRP) for treatment of patients who have experienced brain injury, consisting of: a mixture of human plasma composed of pluripotent adult stem cells comprising very small embryonic like stem cells from autologous plasma or allogeneic plasma, D5W, glutathione, methylcobalamin, and regular insulin. The formulation is infused directly adjacent to a patient's brain through the nostrils or nares of the nasal cavity. Treatment using the formulation may be supplemented with one or more therapies including hyperbaric oxygen therapy (HBOT), cranial osteopathic therapy, intravenous (IV) nutrition, electroencephalographic (EEG) biofeedback, low level laser therapy (LLLT), transcranial magnetic stimulation (TMS), additional PRP pluripotent adult stem cell treatments, and a ketogenic diet and medium-chain triglyceride (MCT) oil therapy.

A composition for a food supplement comprising a substance capable of exerting an anti-oedemigenous and/or anti-inflammatory action in soft organic tissues, a substance capable of exerting an antioxidant action and at least one substance facilitating penetration, through a cell membrane, of the substance capable of exerting an anti-oedemigenous and/or antiinflammatory action and/or of the substance capable of exerting an antioxidant action, for use in the treatment of female infertility.

Gender specific synthetic nutritional compositions for infants up to 1 month of age wherein, the lactoferrin and/or serum albumin content is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.

Gender specific synthetic nutritional compositions for infants up to 1 month of age wherein, the lactoferrin and/or serum albumin content is adapted based on that found in HM produced for an infant of the same gender and age, and nutritional systems comprising them.